These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
515 related articles for article (PubMed ID: 30387807)
1. Knockdown of long non-coding RNA metastasis associated lung adenocarcinoma transcript 1 inhibits the proliferation and migration of bladder cancer cells by modulating the microRNA-34a/cyclin D1 axis. Liu Y; Gao S; Du Q; Zhao Q Int J Mol Med; 2019 Jan; 43(1):547-556. PubMed ID: 30387807 [TBL] [Abstract][Full Text] [Related]
2. Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis. Duan G; Zhang C; Xu C; Xu C; Zhang L; Zhang Y Int J Oncol; 2019 Jan; 54(1):17-28. PubMed ID: 30365098 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression. Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer. Zuo Y; Li Y; Zhou Z; Ma M; Fu K Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533 [TBL] [Abstract][Full Text] [Related]
5. Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Proliferation and Metastasis of Osteosarcoma Cells by Targeting c-Met and SOX4 via miR-34a/c-5p and miR-449a/b. Sun Z; Zhang T; Chen B Med Sci Monit; 2019 Feb; 25():1410-1422. PubMed ID: 30793707 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of lncRNA snoRNA host gene 6 regulates NUAK family SnF1-like kinase-1 expression by competitively binding microRNA-125b and interacting with Snail1/2 in bladder cancer. Wang C; Tao W; Ni S; Chen Q J Cell Biochem; 2019 Jan; 120(1):357-367. PubMed ID: 30168179 [TBL] [Abstract][Full Text] [Related]
7. Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway. Li Z; Ma Z; Xu X Oncol Rep; 2019 Feb; 41(2):1113-1121. PubMed ID: 30431104 [TBL] [Abstract][Full Text] [Related]
8. MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis. Hao T; Wang Z; Yang J; Zhang Y; Shang Y; Sun J Biomed Pharmacother; 2020 Mar; 123():109666. PubMed ID: 31935634 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1/microRNA-202-3p/periostin axis modulates invasion and epithelial-mesenchymal transition in human cervical cancer. Han X; Wang Q; Wang Y; Hu B; Dong X; Zhang H; Wang W J Cell Physiol; 2019 Aug; 234(8):14170-14180. PubMed ID: 30633360 [TBL] [Abstract][Full Text] [Related]
10. MALAT1 promotes angiogenesis of breast cancer. Huang XJ; Xia Y; He GF; Zheng LL; Cai YP; Yin Y; Wu Q Oncol Rep; 2018 Nov; 40(5):2683-2689. PubMed ID: 30226550 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1. Ye J; Li L; Feng P; Wan J; Li J Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA MALAT1 promotes oral squamous cell carcinoma development via microRNA-125b/STAT3 axis. Chang SM; Hu WW J Cell Physiol; 2018 Apr; 233(4):3384-3396. PubMed ID: 28926115 [TBL] [Abstract][Full Text] [Related]
13. The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma. Liu P; Yang H; Zhang J; Peng X; Lu Z; Tong W; Chen J Sci Rep; 2017 Jul; 7(1):5186. PubMed ID: 28701723 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA myocardial infarction associated transcript promotes the proliferation of cholangiocarcinoma cells by targeting miR-551b-3p/CCND1 axis. Chang W; Wang Y; Li W; Geng Z Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1067-1075. PubMed ID: 32064660 [TBL] [Abstract][Full Text] [Related]
15. LncRNA MALAT1 promotes cell proliferation and imatinib resistance by sponging miR-328 in chronic myelogenous leukemia. Wen F; Cao YX; Luo ZY; Liao P; Lu ZW Biochem Biophys Res Commun; 2018 Dec; 507(1-4):1-8. PubMed ID: 30366670 [TBL] [Abstract][Full Text] [Related]
16. LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570-3p. Yue X; Wu WY; Dong M; Guo M Biomed J; 2021 Dec; 44(6 Suppl 2):S296-S304. PubMed ID: 35410813 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA SNHG20 promotes bladder cancer via activating the Wnt/β-catenin signalling pathway. Zhao Q; Gao S; Du Q; Liu Y Int J Mol Med; 2018 Nov; 42(5):2839-2848. PubMed ID: 30106094 [TBL] [Abstract][Full Text] [Related]
18. LncRNA RP11-79H23.3 Functions as a Competing Endogenous RNA to Regulate PTEN Expression through Sponging hsa-miR-107 in the Development of Bladder Cancer. Chi H; Yang R; Zheng X; Zhang L; Jiang R; Chen J Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149689 [TBL] [Abstract][Full Text] [Related]
19. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder. Han Y; Liu Y; Nie L; Gui Y; Cai Z Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939 [TBL] [Abstract][Full Text] [Related]
20. The long non-coding RNA SNHG1 promotes bladder cancer progression by interacting with miR-143-3p and EZH2. Xiang W; Lyu L; Huang T; Zheng F; Yuan J; Zhang C; Jiang G J Cell Mol Med; 2020 Oct; 24(20):11858-11873. PubMed ID: 32885590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]